Debt-to-equity of CalciMedica, Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
CalciMedica, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • CalciMedica, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 623%, a 1046% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

CalciMedica, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 623% +569% +1046% 31 Dec 2025
Q3 2025 154% +96% +163% 30 Sep 2025
Q2 2025 99% +51% +105% 30 Jun 2025
Q1 2025 71% +31% +77% 31 Mar 2025
Q4 2024 54% +13% +31% 31 Dec 2024
Q3 2024 59% +216% 30 Sep 2024
Q2 2024 48% +80% 30 Jun 2024
Q1 2024 40% +58% 31 Mar 2024
Q4 2023 42% +51% 31 Dec 2023
Q3 2023 -158% -152% -2510% 30 Sep 2023
Q2 2023 -31% -18% -136% 30 Jun 2023
Q1 2023 -17% -105% -120% 31 Mar 2023
Q4 2022 -8.9% -20% -180% 31 Dec 2022
Q3 2022 -6% -13% -191% 30 Sep 2022
Q2 2022 -13% -21% -285% 30 Jun 2022
Q1 2022 87% 31 Mar 2022
Q4 2021 11% 31 Dec 2021
Q3 2021 6.6% 30 Sep 2021
Q2 2021 7.2% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.